Ufenamate is an anthranilic acid derivative with anti-inflammatory activity.
This report contains market size and forecasts of Ufenamate in global, including the following market information:
Global Ufenamate Market Revenue, 2017-2022, 2023-2028, ($ millions)
Global Ufenamate Market Sales, 2017-2022, 2023-2028, (Kg)
Global top five Ufenamate companies in 2021 (%)
The global Ufenamate market was valued at million in 2021 and is projected to reach US$ million by 2028, at a CAGR of % during the forecast period.
The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.
Min Purity Less Than 98% Segment to Reach $ Million by 2028, with a % CAGR in next six years.
The global key manufacturers of Ufenamate include Biorbyt, BOC Sciences, Ark Pharm, United States Biological, TCI, Clearsynth, Selleck Chemicals, Biosynth Carbosynth and Adooq Bioscience, etc. In 2021, the global top five players have a share approximately % in terms of revenue.
MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Ufenamate manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Ufenamate Market, by Type, 2017-2022, 2023-2028 ($ Millions) & (Kg)
Global Ufenamate Market Segment Percentages, by Type, 2021 (%)
Min Purity Less Than 98%
Min Purity 98%-99%
Min Purity More Than 99%
Global Ufenamate Market, by Application, 2017-2022, 2023-2028 ($ Millions) & (Kg)
Global Ufenamate Market Segment Percentages, by Application, 2021 (%)
Research
Medical
Global Ufenamate Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions) & (Kg)
Global Ufenamate Market Segment Percentages, By Region and Country, 2021 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Ufenamate revenues in global market, 2017-2022 (Estimated), ($ millions)
Key companies Ufenamate revenues share in global market, 2021 (%)
Key companies Ufenamate sales in global market, 2017-2022 (Estimated), (Kg)
Key companies Ufenamate sales share in global market, 2021 (%)
Further, the report presents profiles of competitors in the market, key players include:
Biorbyt
BOC Sciences
Ark Pharm
United States Biological
TCI
Clearsynth
Selleck Chemicals
Biosynth Carbosynth
Adooq Bioscience
Target Molecule
J&K Scientific